Molecular Insight, Progenics deal

Progenics acquired Molecular Insight in a deal worth up to $105.9 million. Molecular Insight shareholders received 4.6 million Progenics shares valued at $12.9 million based on Progenics' close of $2.83 on Jan. 18, before the deal was announced. Molecular Insight shareholders are also eligible for up to $23 million in commercialization milestones and up to $70 million in sales milestones. ...